BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weber MC, Risch M, Thiel SL, Grossmann K, Nigg S, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Egli K, Bodmer T, Imperiali M, Salimi Y, Fleisch F, Cusini A, Heer S, Renz H, Paprotny M, Kohler P, Vernazza P, Risch L, Kahlert CR. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers 2021;2021:8810196. [PMID: 33532006 DOI: 10.1155/2021/8810196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Brinc D, Biondi MJ, Li D, Sun H, Capraru C, Smookler D, Zahoor MA, Casey J, Kulasingam V, Feld JJ. Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay. Viruses 2021;13:962. [PMID: 34067361 DOI: 10.3390/v13060962] [Reference Citation Analysis]
2 Simonson JL, Esposito C, Frantzen T, Henthorne K, Espinal A, Romano S, Ramdeo R, Trentacoste J, Tsang D, La Vecchia G, Abdullah R, Berdella M, Bonitz L, Condos R, Constantinescu A, Decelie-germana JK, Dimango E, Draine M, Gimeli T, Giusti R, Guzman J, Hammouda S, Keating C, Kier C, Lennox AT, Liriano C, Messer Z, Plachta A, Sadeghi H, Schwind E, Stables-carney T, Walker P, Wang J. THE CLINICAL IMPACT OF THE COVID-19 PANDEMIC FIRST WAVE ON PATIENTS WITH CYSTIC FIBROSIS IN NEW YORK]. Journal of Cystic Fibrosis 2022. [DOI: 10.1016/j.jcf.2022.02.012] [Reference Citation Analysis]
3 Makoah NA, Tipih T, Litabe MM, Brink M, Sempa JB, Goedhals D, Burt FJ. A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19. Future Virol 2021. [PMID: 34950219 DOI: 10.2217/fvl-2021-0211] [Reference Citation Analysis]
4 Wang M, Yu Y, Wu J, Meng F, Tang Y, Wang S, Wang Y, Cui H, He X, Tu Y, Wang G, Cai X. Pathogenic Characterization of a Porcine Circovirus Type 3 Isolate from Heilongjiang, China. Dis Markers 2021;2021:9434944. [PMID: 34257749 DOI: 10.1155/2021/9434944] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Bichara CDA, da Silva Graça Amoras E, Vaz GL, da Silva Torres MK, Queiroz MAF, do Amaral IPC, Vallinoto IMVC, Bichara CNC, Vallinoto ACR. Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population. BMC Infect Dis 2021;21:443. [PMID: 33992073 DOI: 10.1186/s12879-021-06156-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kohler P, Jonsdottir HR, Risch L, Vernazza P, Ackermann-Gäumann R, Kahlert CR. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study. Sci Rep 2021;11:24198. [PMID: 34921220 DOI: 10.1038/s41598-021-03685-y] [Reference Citation Analysis]